Both of these studies combined in silico analysis with extensive functional analysis of a number of MSH2 and PAH variants; however, resources for the latter are unlikely to be routinely available in clinical genetics laboratories. This evidence concerns the gene MSH2 and pulmonary arterial hypertension.